ARCHIVES

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

This article is from The Cancer Letter archive.

Vol. 28 No. 32 | September 6, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI, OMB Heading For November Confrontation Over Hawaii, Papanicolaou Construction Funds

October 17, 1975

In Brief: NCI Scientist Accused Of Taking ‘Payoffs’ Forom Drug Firms; GM-CS Wins FDA Approval

March 15, 1991

Kennedy Tells ASCO Members To Lobby For High Tar, Nicotine Tax

April 7, 1978

Adding Ultrasound Revealed More Breast Cancers In Study

May 30, 2008

First Clinical Guidelines On Ductal Lavage Published

March 29, 2002

Radiotherapy Wing Contractor Dropped

March 27, 1981